Calton & Associates’s CDK Global, Inc. CDK Stock Holding History

Calton & Associates’s Portfolio CDK Stock Details CDK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-207	Closed	-$15K	–	1374
2017 Q4	$15K	Buy	+207	New	+$13.9K	﹤0.01%	965

Other funds holding CDK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SIG

Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return

Calton & Associates's CDK Position: Q1 2018 in Review

Calton & Associates sold out of CDK Global, Inc. (CDK) in Q1 2018, closing a stake of 207 shares — an estimated $15K sold.

Calton & Associates first reported a position in CDK in Q4 2017 and held it in 1 quarter. The position peaked at $15K in Q4 2017. 603 funds tracked by Wall St. Rank hold CDK as of Q1 2018.

Calton & Associates reported no remaining CDK Global, Inc. position as of Q1 2018 after selling out during the quarter.
Calton & Associates sold 207 CDK Global, Inc. shares in Q1 2018, an estimated $15K.
Calton & Associates first reported a position in CDK Global, Inc. in Q4 2017 and held it in 1 quarter.
Calton & Associates's CDK Global, Inc. position peaked at $15K in Q4 2017.
603 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.